Urinary Diversion will be of great value for the urologist in training or in practice who wishes to not only expand the repertoire of urinary diversions offered to patients but also refine techniques of managing common complications.
2 Selection of Urinary Diversion
3 Considerations for Continent Diversion in Women
4 Orthotopic Diversion in Men
5 Orthotopic Diversion in Women
6 Continent Cutaneous Diversion
7 Management of Cutaneous Stomal Complications
8 Management of Complications of Ileal Conduit Stoma
9 Robotic Intracorporeal Urinary Diversion
10 Use of Regenerative Tissue for Urinary Diversion
11 Long-term Complications of Urinary Diversion
12 Health Related Quality of Life with Urinary Diversion
13 Considerations for Urinary Re-Diversion
Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University and was then recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director.Dr. Daneshmand's main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience with radical cystectomy and continent urinary diversion. His main research interests focus on the use of pathways to improve peri-operative outcomes following radical cystectomy, use of serum and molecular markers and new technologies in diagnosis and management of bladder cancer, as well as functional outcomes following continent urinary diversion. He is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy and his protocol has significantly reduced hospital stay while improving the patient experience. He serves on the editorial board of the Bladder Cancer Journal, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the American Urological Society/ Society of Urologic Oncology Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the "America's Top Cancer Doctors" for numerous consecutive years. He is an active member of the Society of Urologic Oncology, has presented over 300 abstracts at scientific meetings and has authored over 200 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.
“This comprehensive book on urinary diversion after radical cystectomy covers techniques to create open and robotic approaches to both continent and incontinent urinary diversions. … The intended audience is senior level trainees or experienced surgeons who are considering expanding their knowledge base regarding urinary diversion after cystectomy. It is also a useful reference for physician extenders who may be involved in preoperative counseling or postoperative follow up of these complicated patients.” (James R. Mark, Doody's Book Reviews, August, 2017)